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ABSTRACT
Background: One of the most common cancers is skin cancer worldwide. Since incidence and 
cost of treatment of the cancer are increasing, it is necessary to further investigate to prevent and 
control this disease. This study aimed to determine skin cancer trend and epidemiology in Iran.
Methods: This study was done based on existing data. Data used in this study were obtained from 
a national registry of cancer cases and the Disease Management Center of Ministry of Health in 
Iran. All cases registered in the country were included during 2004–2008. Incidence rates were 
reported based on the direct method and standard population of World Health Organization.
Results: Based on the results of this study, the incidence of skin cancer is rising in Iran and the 
sex ratio was more in men than women in all provinces. The age-standardized incidence rate 
(ASR) of skin cancer was highest in males in Semnan, Isfahan, and Hamedan provinces (34.9, 
30.80, and 28.84, respectively). The highest ASRs were seen in females in Semnan, Yazd, and 
Isfahan provinces (26.7, 24.14, and 18.97, respectively). The lowest ASR in male was observed 
in Sistan and Baluchestan, and in female in Hormozgan provinces.
Conclusions: The incidence of skin cancer is increasing in the country. Therefore, the plan for 
the control and prevention of this cancer must be a high priority for health policy makers.
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carcinoma and squamous cell carcinoma).[2] Monitoring 
of skin cancer indicates an increase in the incidence of 
the disease.[1] In the Netherlands, the incidence of cancer 
has increased 80% from 2000 to 2005,[3] and in Brazil, this 
rate has reached from 50 new cases in 2000 to 94 cases 
per 100,000 people in 2006.[4] In Iran, about 15% of all 
cancer was skin cancer and this disease consider as the 
most common cancer.[5]
In addition, the financial impact of cancer can 
significantly affect a community resource. Treatment 
cost of the cancer goes beyond the 500 million dollars 
per year in the United States.[6] In Australia in 2010, it 
is estimated at around 511 million dollars.[7] Although 
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INTRODUCTION
Skin cancer is one of the most common cancers in the 
world, especially in the whites.[1] The cancer includes 
two types of melanoma and non-melanoma (basal cell 
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deaths from this of cancer are low, what is more 
painful than the mortality rate of this type of cancer 
is emotional and physical suffering from it. Important 
activities are not done in understanding the etiology and 
molecular basis of cancer.[8,9]
The most important risk factors for skin cancer are 
individual, genetic, and environmental factors.[10] Factors 
such as skin color, eye color, hair color, aging, and 
sometimes immunodeficiency are considered genetic 
factors and individual characteristics affecting the risk 
of skin cancer.[10] Environmental factors are Exposure to 
ultraviolet solar radiation, decreasing latitude, high intake 
of alcohol, and consumption of high-fat foods, long-term 
activities in the outdoors, and cover change.[11-14]
Although skin cancer is a common cancer, it is one of 
the most preventable types of cancers.[15] The primary 
prevention in the earlier stage, the impact will be 
greater. Considering the high incidence of this cancer in 
Iran as the most common cancer, and the absence of a 
comprehensive and systematic study on the trend of the 
disease, this study aimed to determine skin cancer trend 
and epidemiology in Iran.
METHODS
This analytic study was done based on longitudinal 
program in Iran that similar to many countries in the 
world that have national registry of cancer (NCR) is 
trying to identify all cases of cancer occurring in Iran 
from 2004 to 2008. Data used in this study were obtained 
from a NCR, and Disease Control and Prevention (CDC) 
of Ministry of Health and Medical Education in Iran for 
2004–2008.[16] In 2008 in Iran, there are 30 provinces 
and 41 Medical Universities. Deputy for the health of 
each university is responsible for health issues of the 
population and all health activities are managed by these 
deputies. All deputies for health have been included in 
the NCR. Registrar would apply the national registration 
software, which was developed by CDC. For pathologic 
centers, without software, the cancer records were 
gathered manually. The cancer office of CDC should 
provide techniques and funding supports. The data are 
transmitted every 3 months, by electronic file and also 
hard copy of “Cancer Registry Data Collection Form;” 
this form is comprised of three parts: Part I, regarding 
patient’s identity characteristics in addition to the name 
of biopsy-taker physician, name of hospital, location of 
which the biopsy is taken, clinical diagnosis and date of 
biopsy sent to histological laboratory and demographic 
information of the patients includes race and residence. 
Part II includes the most important findings of patient’s 
clinical history. Part III includes preclinical findings. The 
information includes the primary location of the tumor, 
date of cancer diagnosis, morphology, and histology and 
its behavior and diagnosis method. Physicians fill the 
form of clinical data and the official personnel fill the 
identity and demographic information. Quality control 
has been coordinated in five main areas by cancer 
office of CDC: (i) Regarding completeness of coverage, 
(ii) completeness of details, (iii) accuracy of data, 
(iv) accuracy of reports, (v) accuracy of interpretation, 
and (vi) repeated cases are deleted from national 
data. Surveillance of pathology is based on the cancer 
record in several selected provinces to compare it 
with the present pathology cancer record for a general 
and complete evaluation and also for the accuracy of 
the collected data. IARC software provides a way to 
identify inaccuracies in data coding. Accordance of The 
International Classification of Diseases for Oncology 
(ICD-OC: Topography with ICD-OM: Morphology) 
is done manually and also by considering age and sex 
groups (pathology file of fatal error has been revised by 
the Scientific Society of Pathology of Iran and also by 
two masters in pathology).
Method for deleting repeated cases: For the lack of any 
classified National Identification Numbers, the process 
for deleting the repeated cases was completed by a 
manual review of the record. After editing data of each 
province and considering in mind that for deleting of 
repeated cases, similar cases should also be the same 
as morphology, topography, identity, and demographic 
information; deletion of the repeated cases would be 
done separately in each province and finally in all over 
country by experienced manual reviewers. In duration 
of study (2003–2008), the number of cancer case that 
repetition and delegating from list of all type of cancers 
was 38,468, 47,217, 55,854, 59,786, 62,040, and 76,159, 
respectively. Furthermore, between of 25% and 39.5% 
of patients have defected in coding [Diagram 1]. We 
consider skin cancer in four types: Basal cell carcinoma, 
squamous cell carcinoma, malignant melanoma, and 
basosquamous carcinoma.
Crude (all ages) and age-specific rates per 100,000 
person-year for all provinces were calculated. For each 
province, the average annual age-standardized incidence 
rate (ASR) per 100,000 person-year was calculated by 
the direct method using the world standard population.
RESULTS
Findings obtained from the national registry system of 
cancer showed that the incidence of skin cancer had 
increasing trend from 2004 to 2008 [Figure 1]. That 
is, 43,694 cases of skin cancer have been registered in 
the country. Of the incidence cases, 27,364 cases were 
male and Sex ratio was 1.67 in these years. The highest 
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incidence rate (9964 cases) was observed in 2008, but the 
lowest rate (7320 cases) was recorded in 2004 [Table 1].
The age-specific rate in men increased from 17 in 2004 
to 22.62 in 2008. The highest and lowest incidence rate 
in men observed in 2004 and 2008, respectively. The 
trend of skin cancer incidence in man was increasing; 
on an average, it grew by 07.06% annually. In women, 
this rate also elevated from 12.01 in 2004 to 15.77 in 
2008 per 100,000 people. The maximum and minimum 
incidence rates were 17.77 and 12.01 per 100,000 people, 
respectively in 2008 and 2004. Furthermore, in women 
trend of skin cancer incidence was increasing; on an 
average, it grew by 06.59% annually. The highest and 
lowest sex ratios were 1.69 and 1.63, respectively in 2008 
and 2004 [Table 1 and Figure 1].
In this study, the age-specific rate was different in age 
groups so that as age rises, the incidence of skin cancer 
in men and women was increased, and the highest rate 
was observed at 80–84 years but it decreased at above 
85 years. Furthermore, the age-specific rate in overall has 
rising trends from 2004 to 2008 [Table 2].
In 2008, the age-specific rate of skin cancer was highest in 
males in Semnan, Isfahan, and Hamedan provinces (34.9, 
30.80, and 28.84, respectively). The highest ASRs were 
seen in females in Semnan, Yazd, and Isfahan provinces 
(26.7, 24.14, and 18.97, respectively). The lowest ASR 
in male was observed in Sistan and Baluchestan, and in 
female in Hormozgan provinces [Table 3].
Basal cell carcinoma, squamous cell carcinoma, 
malignant melanoma, and basosquamous carcinoma in 
two gender have a rising trend in study duration, so in 
male Basosquamous carcinoma has maximum rising in 
annually incidence average 16.75% and minimum basal 
cell carcinoma with 03.14% and in female Squamous cell 
carcinoma has maximum rising in annually incidence 
average 08% and minimum in basal cell carcinoma with 
04% [Table 4].
DISCUSSION
The findings indicated that the incidence of skin cancer 
was increasing. The trend was observed in all provinces. 
The highest incidence rate of skin cancer was in males in 
Semnan, Isfahan, and Hamedan provinces. The highest 
incidence rates were seen in females in Semnan, Yazd, 
and Isfahan provinces. The lowest ASR in male was 
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observed in Sistan and Baluchestan, and in female in 
Hormozgan provinces the incidence of the disease was 
more in all provinces in men than women. There was a 
direct association between skin cancer and age so that 
the incidence of skin cancer was increased as age rises.
The results of this study showed that, during the period 
2003 through 2008, the trend of skin cancer incidence 
in Iran was increasing; on an average, it grew by 07.22% 
annually, extensive amount of this growing was certainly 
related to the enhancement of the registry and reporting 
system. In addition, the low incidence rate of cancer 
in 2004 was not due to the fact that few cancer cases 
occurred, but rather owing to the incomplete registration 
of cancer cases at the beginning of the cancer registry 
program. Iranian national reports of cancer registry 
showed that the average annual percentage change 
for standardized incidence rate in all cancer was 9.6% 
in males and 10.6% in females during 2003–2008,[16] 
Other studies also confirmed the increasing trend of 
the cancer.[17] In addition this reason, various other 
factors may be effective in rising trend of incidence 
skin cancer in Iran. These factors include climate 
changes, environmental factors, promoting awareness, 
and advances in diagnosis.[13,14,22-25] The most important 
etiologic agent of all types of skin cancer is ultraviolet 
radiation.[26]
As the approach the equator, melanoma and non-
melanoma cancers have linearly increased.[26] In other 
words, skin cancer is twice when latitude reduced nearly 
10°. It revealed the increasing incidence of skin cancer 
in different races.[26] el Khwsky et al. expressed a relation 
between skin color and sun exposure. The incidence of 
skin cancer in people who have had excessive exposure to 
sunlight than other people was 4.8 times. In most seasons 
of the year, the intense radiation of the sun and lack of 
using suitable protection for outdoor in Iran can probably 
lead to high incidence of the disease.[27]
According to rising life expectancy and the mean age of 
population in our country, increasing the incidence of 
Table 1: Frequency, CIR, and ASR‑based of sex and year
Years Frequency (%) CIR ASR Male:Female
Male Female Total Male Female Male Female
2004 4541 2779 7320 (15.50) 13.09 8.44 17 12.01 1.63
2005 5321 3162 8483 (15.18) 14.72 9.22 19.15 13.16 1.68
2006 5515 3290 8805 (14.72) 15.32 9.63 20.16 13.85 1.67
2007 5719 3403 9122 (14.70) 15.89 9.96 20.87 14.51 1.68
2008 6268 3696 9964 (13.08) 17.41 10.82 22.62 15.77 1.69
ASR=Age‑standardized incidence rate, CIR=Crude incidence rate
Table 2: The ASR according to age group and gender
Age‑category 2004 2005 2006 2007 2008
Male Female Male Female Male Female Male Female Male Female
0-4 0.00 0.00 0.00 0.00 0.07 0.00 0.03 0.04 0.20 0.07
5-9 0.03 0.00 0.03 0.03 0.03 0.05 0.08 0.00 0.36 0.16
10-14 0.06 0.05 0.06 0.00 0.08 0.13 0.06 0.04 0.22 0.13
15-19 0.17 0.19 0.29 0.35 0.15 0.23 0.37 0.15 0.33 0.27
20-24 0.58 0.70 0.92 0.95 0.92 0.73 1.19 0.73 1.04 1.09
25-29 1.69 1.18 1.92 1.39 2.16 1.77 1.86 1.66 1.92 2.17
30-34 3.84 2.28 3.40 2.64 2.56 2.98 3.17 2.45 3.95 2.98
35-39 4.63 4.50 5.56 5.28 5.11 4.24 5.07 4.63 6.74 4.92
40-44 9.78 8.04 10.79 7.08 10.13 7.59 9.16 8.07 10.84 7.17
45-49 20.73 16.68 21.08 14.79 17.90 16.58 20.35 15.50 18.53 16.87
50-54 54.85 26.90 56.78 31.47 58.61 29.40 60.74 31.43 58.29 33.29
55-59 52.00 37.48 60.06 39.49 69.44 43.78 72.11 49.86 79.74 57.03
60-64 57.17 51.82 68.32 57.00 66.06 62.84 74.38 64.66 78.84 72.86
65-69 64.08 51.13 71.78 56.62 77.92 58.02 74.88 57.35 77.69 68.28
70-74 114.77 69.82 134.23 81.46 139.36 83.33 133.40 88.74 159.09 80.43
75-79 113.82 85.96 123.29 99.53 132.70 104.86 150.79 105.52 170.99 110.78
80-84 255.72 165.82 326.83 197.84 368.99 196.83 366.22 228.43 417.15 237.46
85+ 142.61 82.64 152.63 81.34 218.25 109.89 233.11 123.00 260.00 143.165
ASR=Age‑standardized incidence rate
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skin cancer, especially in the older age, may be justifiable. 
Other studies, similar our study, showed as age increases, 
the incidence of cancer will increase.[20,28]
Another research also determined that high incidence of 
the cancer in men than women.[28] In our study, such a 
result was observed in all provinces.
Table 3: Trend of ASR in Iranian province from 2004 to 2008
Province Years (ASR)
2004 2005 2006 2007 2008
Male Female Male Female Male Female Male Female Male Female
Ardebil 16.33 13.70 10.27 6.49 20.16 13.85 9.44 8.37 11.63 8.33
Bushehr 10.34 7.72 13.72 11.40 12.45 9.97 11.22 11.67 12.15 8.49
Chaharmahal and Bakhtiari 19.40 33.35 21.89 10.84 19.66 8.25 17.59 12.99 19.21 11.88
East Azerbaijan 16.35 10.58 6.43 3.93 6.80 3.08 20.93 14.14 24.89 16.92
Fars 12.56 10.18 15.40 12.72 15.07 12.99 22.02 17.53 27.31 19.16
Ghazvin 22.29 17.78 22.13 17.42 22.34 13.79 22.30 14.93 24.74 18.75
Gilan 10.67 5.08 17.42 13.62 14.70 10.83 16.98 14.33 19.89 15.97
Golestan 13.23 6.40 5.97 7.51 12.27 5.62 12.75 8.86 12.23 7.31
Hamedan 17.03 8.64 20.37 10.28 21.33 15.40 23.34 15.59 28.84 15.55
Hormozgan 7.38 4.77 2.67 5.01 4.14 4.45 5.63 4 4.77 3.51
Ilam 13.75 17.58 11.95 6.91 18.66 13.28 25.66 15.95 23.98 15.12
Isfahan 28.44 18.30 25.65 15.98 27.63 19.36 30.54 20.12 30.80 18.97
Kerman 11.63 10.73 10.85 7.32 13.45 11.98 13.07 13.80 15.73 14.62
Kermanshah 18.98 17.54 23.16 18.34 20.55 17.45 19.63 15.60 24.39 18.23
Khorasan Razavi - - 13.25 9.51 22.81 16.54 20.71 14.70 22.53 15.11
Khuzestan 13.04 8.02 11.40 8.11 12.83 9.62 15.50 11.06 18.71 16.43
Kohkiloueh and Boyerahmad 28.02 15.92 16.23 11.95 23.05 13.61 20.72 14.91 17.87 17.27
Kurdistan 17.55 18.59 20.91 13.44 17.87 10.50 21.63 12.87 24.69 18.21
Lorestan 24.76 13.51 19.52 12.34 23.96 15.96 20.70 16.40 23.03 15.98
Markazi 19.71 10.46 20.58 14.14 24.91 16.18 22.17 13.90 25.53 10.54
Mazandaran 13.21 12.26 13.60 10.75 19 13.02 13.26 10.46 17.07 15.21
North Khorasan - - 11.42 8.17 12.59 8.11 21.42 14.42 16.93 15.32
Qom 17.79 11.34 14.43 9.63 14.32 8.08 13.01 10.63 14.19 9.07
Semnan 13.29 7.89 11.56 12.26 18.03 17.78 23.79 13.24 34.90 26.07
Sistan and Balochestan 2.22 1.50 3.76 3.84 3.89 3.01 3.10 3.58 4.72 3.84
South Khorasan 11.29 10.64 9.32 10.52 10.58 11.79 13.24 10.27
Tehran 11.52 8.99 16.33 10.17 18.67 12.06 18.72 11.02 28.16 18.03
West Azerbaijan 16.55 11.47 15.06 10.40 14.29 10.48 13.88 10.17 19.07 13.82
Yazd 23.15 19.68 25.11 23.30 22.76 17.51 22.09 21.02 27.10 24.14
Zanjan 18.64 9.79 19.63 12.72 16.38 9.45 25.05 12.77 17.73 14.85
ASR=Age‑standardized incidence rate
Table 4: The frequency and percent of occurrence of skin cancer in Iran from 2004 to 2008
2004 2005 2006 2007 2008
n % n % n % n % n %
Female
Basal cell carcinoma, nos 2108 75.85 2232 70.59 2274 69.12 2266 66.59 2439 65.99
Squamous cell carcinoma, nos 351 12.63 450 14.23 440 13.37 477 14.02 469 12.69
Malignant melanoma, nos 80 2.88 85 2.69 91 2.77 105 3.09 123 3.33
Basosquamous carcinoma 37 1.33 62 1.96 59 1.79 54 1.59 68 1.84
Male
Basal cell carcinoma, nos 3084 67.91 3380 63.53 3349 60.73 3362 58.79 3701 59.05
Squamous cell carcinoma, nos 941 20.72 1194 22.44 1232 22.34 1337 23.38 1319 21.04
Malignant melanoma, nos 122 2.69 134 2.52 112 2.03 145 2.54 154 2.46
Basosquamous carcinoma 73 1.61 88 1.65 111 2.01 118 2.06 102 1.63
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Daily activities in outdoor and sunny environments or 
contact with the carcinogen can be main factors cause to 
the high rate of the cancer in males.[29,30] It recommended 
that in the area that age-specific rate is higher than 
the national average, appropriate studies to identify 
environmental, cultural, biological and so, designed 
to identify the factors affecting the occurrence of the 
disease in these areas.
Strengths and limitations
Though the study well assessed incidence and age-specific 
rates of skin cancer based on the area, type of disease, 
age, and sex groups in Iran from 2004 to 2008, that given 
the extent of the time and place of the study, can have 
valuable results. However, it should be stated that the 
cancer registry system in Iran is still not fully and equally 
in all area and sometimes the differences in the quality 
and coverage of data is observed. Furthermore, in this 
study, despite the continued increase in the incidence 
of disease with rising the age, the disease in the age 
group 85 years, and elders is less than the previous age 
group, a possible reason was reduce in physician meeting 
in this age group for skin problem and reduce skin cancer 
diagnosis. In addition, we observed that provinces with 
the highest incidence rates in males were different from 
those where the highest rates of female cancers but with 
note to my study design; we can’t determent cause of 
this different.
CONCLUSIONS
The incidence of skin cancer is increasing in the country. 
Therefore, the plan for the control and prevention of this 
disease must be a high priority for health policy makers. 
Our findings were obtained from the descriptive study 
on the incidence trend of the disease in recent years 
and it is recommended that analytical studies should 
be conducted to obtain a causal relationship and solve 
problems related to the disease.
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